Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1285-1291

  Oshima, Takashi ^a   Kunisaki, Chikara ^a   Yoshihara, Kazue ^a   Yamada, Roppei ^a   Yamamoto, Naoto ^a   Sato, Tsutomu ^a   Makino, Hirochika ^a   Yamagishi, Shigeru ^a   Nagano, Yasuhiko ^a   Fujii, Shoich ^a   Shiozawa, Manabu ^b   Akaike, Makoto ^b   Wada, Nobuyuki ^c   Rino, Yasushi ^c   Masuda, Munetaka ^c   Tanaka, Katsuaki ^a   Imada, Toshio ^d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c Department of First Surgery ^*  (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Kazal motifs; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Membrane type matrix metalloproteinase 1

Indexed keywords

BETA ACTIN; CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; LIGAND; RECK PROTEIN, HUMAN;

AGED; ARTICLE; CANCER INVASION; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; COLORECTAL TUMOR; ENZYMOLOGY; GENE EXPRESSION REGULATION; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROTEIN MOTIF;

AGED; AMINO ACID MOTIFS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 47549116029     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1285     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
2. Greenwald P: Colon cancer overview. Cancer 70: 1206-1215, 1992.
3. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
4. Wagenaar-Miller RA, Gorden L and Matrisian LM: Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23: 119-135, 2004.
5. Noda M, Kitayama H, Matsuzaki T, et al: Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci USA 86: 162-166, 1989.
6. Mook OR, Frederiks WM, Van C and Noorden J: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004.
7. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y and Noda M: A ras-related gene with transformation suppressor activity. Cell 56: 77-84, 1989.
8. Takahashi C, Akiyama N, Matsuzaki T, Takai S, Kitayama H and Noda M: Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Oncogene 12: 2137-2146, 1996.
9. Takahashi C, Sheng Z, Horan TP, et al: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221-13226, 1998.
10. Sasahara RM, Takahashi C and Noda M: Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 264: 668-675, 1999.
11. Oh J, Takahashi R, Kondo S, et al: The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800, 2001.
12. Weaver VM: Membrane-associated MMP regulators: novel cell adhesion tumor suppressor proteins? Dev Cell 2: 6-7, 2002.
13. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
14. Liotta LA and Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106, 1990.
15. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
16. Jadhav U, Chigurupati S, Lakka SS and Mohanam S: Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25: 1407-1414, 2004.
17. Folgueras AR, Pendas AM, Sanchez LM and Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004.
18. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114: 33-45, 2003.
19. Kim TD, Song KS, Li G, et al: Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 6: 211, 2006.
20. Lubbe WJ, Zhou ZY, Fu W, et al: Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res 12: 1876-1882, 2006.
21. Atkinson JM, Pennington CJ, Martin SW, et al: Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activity. Eur J Cancer 43: 1764-1771, 2007.
22. Takeuchi T, Hisanaga M, Nagao M, et al: The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 10: 5572-5579, 2004.
23. Zheng H, Takahashi H, Murai Y, et al: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26: 3579-3583, 2006.
24. Ogata Y, Matono K, Sasatomi T, et al: The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. Cancer Chemother Pharmacol 57: 577-583, 2006.
25. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994.
26. van der Jagt MF, Sweep FC, Waas ET, et al: Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer. Cancer Lett 237: 289-297, 2006.
27. Masui T, Doi R, Koshiba T, et al: RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9: 1779-1784, 2003.